>
Powered by

RXi Pharmaceuticals to Present at the 5th Annual Cancer BioPartnering & Investment Forum

 RXi Pharmaceuticals Corporation (NASDAQ: RXII), a clinical-stage RNAi company developing innovative therapeutics that address significant unmet medical needs, today announced Alexey Eliseev, PhD, RXi's Chief Business Officer, will present at the 5th Annual Cancer BioPartnering & Investment Forum. The forum will provide a platform to present to and meet with thought leaders from cancer research institutes, leading pharmaceutical and biotech companies as well as institutional investors. This eve

Sign up for unrestricted access to 200+ subscription services.
Already have an account? Click here to login.

RelSci News & Alerts gets you:

  • 5 free articles a month from top subscription outlets like the Financial Times, New York Times, and Washington Post
  • Competitive business intelligence through daily data updates
  • Custom feeds on target high-value individuals, companies, industries, and topics delivered straight to your inbox